Designed to improve circulation
The Venowave is an FDA approved circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation. When worn firmly on the calf, the Venowave produces a wave form motion forcing blood from the feet and legs back to the heart. This increase in blood flow draws oxygen to wound and ulcer sites, prevents blood pooling and clotting, and alleviates symptoms of Post Thrombotic Syndrome and other Chronic Venous Insufficiencies. The product is unique because it is lightweight (250 g or less than ½ a pound), discreet (can be worn under pants or skirts easily), and allows patients to remain completely mobile. There are no wires or tubes.
Designed to improve circulation
The Venowave is an FDA approved circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation. When worn firmly on the calf, the Venowave produces a wave form motion forcing blood from the feet and legs back to the heart. This increase in blood flow draws oxygen to wound and ulcer sites, prevents blood pooling and clotting, and alleviates symptoms of Post Thrombotic Syndrome and other Chronic Venous Insufficiencies. The product is unique because it is lightweight (250 g or less than ½ a pound), discreet (can be worn under pants or skirts easily), and allows patients to remain completely mobile. There are no wires or tubes.

Compliance

Venowave™ smoothly and quietly compresses the calf 4–5 times per minute to pump blood out of the leg. The patient feels a gentle massage sensation that allows them to sleep comfortably.

Efficacy

Venowave™ has been in field use for over ten years. Studies have shown it to be as effective or better than pharmaceutical prophylaxes. It can be used alone or in conjunction with other therapies for a synergistic effect.

Safety

There are no hoses, wires or tubes to create a tripping or fall risk. There are no risks of overheating due to venting of hot air or charging lithium batteries. Patient is never tethered to a wall outlet.

The product is unique because it is lightweight​

The product is unique because it is lightweight

The product is unique because it is lightweight (250 g or less than ½ a pound), discreet (can be worn under pants or skirts easily), and allows patients to remain completely mobile. There are no wires or tubes, unlike competing products such as sequential compression devices.

Simple and Easy to Use

Venowave is precision engineered and easy to maintain.  Venowave can be cleaned and maintained simply by wiping it down.  Replacement soft goods (leg wraps) are also available should the wraps on your units become dirty or otherwise unusable

Venowave - Designed 
to improve circulation
  1. Insert supplied rechargeable battery into Venowave unit.
  2. Attach Venowave unit to leg using the adjustable straps.
  3. Press the power button to activate Venowave.

Anticoagulants can be administered in-hospital or out with high patient compliance rates. While they are easy to administer, all entail risk of bleeds and may be quite expensive. There is an almost direct relationship between the safety of their use and its cost, ranging from moderate-risk, high-cost hospital administration by injection to higher-risk, lower cost oral self-administration at home. The risks are harm to the patient and enormous cost to the hospital, under BCI, for rehospitalisation.

Compression cuffs have long been used during in-hospital recovery from surgery and have been shown to be as effective or better at preventing DVTs as anticoagulants or high-dose aspirin and more effective than low-dose aspirin alone. In addition, studies of mobile compression devices have shown them to be much safer than anticoagulants.

Symptomatic venous thromboembolic rates observed in patients who had an arthroplasty of a lower-extremity joint using the mobile compression device were not worse than the rates reported for pharmacological prophylaxis, including warfarin, enoxaparin, rivaroxaban, and dabigatran.

When compared with low-molecular-weight heparin (LMWH), use of the mobile compression device for prophylaxis against venous thromboembolic events following total hip arthroplasty resulted in a significant decrease in major bleeding events: 6% of subjects in LMWH injections group vs 0% in mobile compression device group. In normal use, the compression devices used in hospitals have several advantages over most at-home compression devices.

  • Up to 24 hours of continuous operation on a single charge for easy ambulatory use
  • Quick easy swap of externally charged duplicate batteries for discharged set
  • Long battery life allows a full night’s sleep
  • System is about 15 dB quieter than pneumatic systems for undistracted day use and ease of sleep
  • Anecdotal evidence suggests that steady massaging action goes largely unnoticed by users
  • Positive displacement pumping action adjusts to patient body position applying pressure of up to 130 mm of mercury
  • Compliance meter can be read on the device

Pricing

Please Contact

What’s included:

  • 2 Venowave units
  • Battery charger
  • Rechargeable batteries
  • Instruction guide

Subscribe

Subscribe today, and receive a special discount code for another Therma Bright product.
Sign up below to receive a discount code.